Chan, Y., Hsu, T., Wang, C., Kao, Y., Huang, C., & Chu, P. (2020). Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function. ESC Heart Fail.
Chicago-tyylinen lähdeviittausChan, Yi‐Hsin, Tzyy‐Jer Hsu, Chun‐Li Wang, Yi‐Wei Kao, Chien‐Ying Huang, ja Pao‐Hsien Chu. "Sodium Glucose Cotransporter‐2 Inhibitor Was Associated With an Improvement in Left Ventricular Systolic Function in Patients With Type 2 Diabetes Mellitus With Impaired Left Ventricular Systolic Function." ESC Heart Fail 2020.
MLA-viiteChan, Yi‐Hsin, et al. "Sodium Glucose Cotransporter‐2 Inhibitor Was Associated With an Improvement in Left Ventricular Systolic Function in Patients With Type 2 Diabetes Mellitus With Impaired Left Ventricular Systolic Function." ESC Heart Fail 2020.